Population pharmacokinetics and pharmacodynamics of nirmatrelvir in Chinese patients with COVID-19
Description
CONCLUSIONS: In all, our findings suggest no ethnic PK differences, a weak and clinically insignificant relationship between drug exposure and efficacy, suitable dosage for Chinese patients (including the elderly) based on PK parameters, and the need
